Cancer Research Meeting Calendar  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koed, K.
Right arrow Articles by Ørntoft, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koed, K.
Right arrow Articles by Ørntoft, T. F.
[Cancer Research 65, 34-45, January 1, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology and Genetics

High-Density Single Nucleotide Polymorphism Array Defines Novel Stage and Location-Dependent Allelic Imbalances in Human Bladder Tumors

Karen Koed1,3, Carsten Wiuf4, Lise-Lotte Christensen1, Friedrik P. Wikman1, Karsten Zieger1,2, Klaus Møller2, Hans von der Maase3 and Torben F. Ørntoft1

Molecular Diagnostic Laboratory,1 Departments of Clinical Biochemistry,2 Urology, and 3 Oncology, Aarhus University Hospital; and 4 Bioinformatics Research Center, Aarhus University, Aarhus, Denmark

Requests for reprints: Torben F. Ørntoft, Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, DK-8200 Aarhus, Denmark. Phone: 45-894-95100; Fax: 45-894-96018; E-mail: orntoft{at}kba.sks.au.dk.

Bladder cancer is a common disease characterized by multiple recurrences and an invasive disease course in more than 10% of patients. It is of monoclonal or oligoclonal origin and genomic instability has been shown at certain loci. We used a 10,000 single nucleotide polymorphism (SNP) array with an average of 2,700 heterozygous SNPs to detect allelic imbalances (AI) in 37 microdissected bladder tumors from 17 patients. Eight tumors represented upstaging from Ta to T1, eight from T1 to T2+, and one from Ta to T2+. The AI was strongly stage-dependent as four chromosomal arms showed AI in > 50% of Ta samples, eight in T1, and twenty-two in T2+ samples. The tumors showed stage-dependent clonality as 61.3% of AIs were reconfirmed in later T1 tumors and 84.4% in muscle-invasive tumors. Novel unstable chromosomal areas were identified at chromosomes 6q, 10p, 16q, 20p, 20q, and 22q. The tumors separated into two distinct groups, highly stable tumors (all Ta tumors) and unstable tumors (2/3 muscle-invasive). All 11 unstable tumors had lost chromosome 17p areas and 90% chromosome 8 areas affecting Netrin-1/UNC5D/MAP2K4 genes as well as others. AI was present at the TP53 locus in 10 out of 11 unstable tumors, whereas 6 had homozygous TP53 mutations. Tumor distribution pattern reflected AI as seven out of eight patients with additional upper urinary tract tumors had genomic stable bladder tumors (P < 0.05). These data show the power of high-resolution SNP arrays for defining clinically relevant AIs.

Key Words: bladder cancer • single nucleotide polymorphism • loss of heterozygosity • allelic imbalance • TP53 mutations




This article has been cited by other articles:


Home page
JCOHome page
Y.-T. Huang, R. S. Heist, L. R. Chirieac, X. Lin, V. Skaug, S. Zienolddiny, A. Haugen, M. C. Wu, Z. Wang, L. Su, et al.
Genome-Wide Analysis of Survival in Early-Stage Non-Small-Cell Lung Cancer
J. Clin. Oncol., June 1, 2009; 27(16): 2660 - 2667.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. J.H. Coenen, M. Ploeg, M. M.V.A.P. Schijvenaars, E. B. Cornel, H. F.M. Karthaus, H. Scheffer, J. A. Witjes, B. Franke, and L. A.L.M. Kiemeney
Allelic Imbalance Analysis Using a Single-Nucleotide Polymorphism Microarray for the Detection of Bladder Cancer Recurrence
Clin. Cancer Res., December 15, 2008; 14(24): 8198 - 8204.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Veerakumarasivam, H. E. Scott, S.-F. Chin, A. Warren, M. J. Wallard, D. Grimmer, K. Ichimura, C. Caldas, V. P. Collins, D. E. Neal, et al.
High-Resolution Array-Based Comparative Genomic Hybridization of Bladder Cancers Identifies Mouse Double Minute 4 (MDM4) as an Amplification Target Exclusive of MDM2 and TP53
Clin. Cancer Res., May 1, 2008; 14(9): 2527 - 2534.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. A. Rauch, X. Zhong, X. Wu, M. Wang, K. H. Kernstine, Z. Wang, A. D. Riggs, and G. P. Pfeifer
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer
PNAS, January 8, 2008; 105(1): 252 - 257.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. L. Andersen, C. Wiuf, M. Kruhoffer, M. Korsgaard, S. Laurberg, and T. F. Orntoft
Frequent occurrence of uniparental disomy in colorectal cancer
Carcinogenesis, January 1, 2007; 28(1): 38 - 48.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
D. A. Peiffer, J. M. Le, F. J. Steemers, W. Chang, T. Jenniges, F. Garcia, K. Haden, J. Li, C. A. Shaw, J. Belmont, et al.
High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping
Genome Res., September 1, 2006; 16(9): 1136 - 1148.
[Abstract] [Full Text] [PDF]


Home page
Proc R Soc AHome page
C. Wiuf and M. P.H Stumpf
Binomial subsampling
Proc R Soc A, April 8, 2006; 462(2068): 1181 - 1195.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Aaboe, K. Birkenkamp-Demtroder, C. Wiuf, F. B. Sorensen, T. Thykjaer, G. Sauter, K. M.-E. Jensen, L. Dyrskjot, and T. Orntoft
SOX4 Expression in Bladder Carcinoma: Clinical Aspects and In vitro Functional Characterization.
Cancer Res., April 1, 2006; 66(7): 3434 - 3442.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. A. Knowles
Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?
Carcinogenesis, March 1, 2006; 27(3): 361 - 373.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. H. Lips, J. W. F. Dierssen, R. van Eijk, J. Oosting, P. H.C. Eilers, R. A.E.M. Tollenaar, E. J. de Graaf, R. van't Slot, C. Wijmenga, H. Morreau, et al.
Reliable High-Throughput Genotyping and Loss-of-Heterozygosity Detection in Formalin-Fixed, Paraffin-Embedded Tumors Using Single Nucleotide Polymorphism Arrays
Cancer Res., November 15, 2005; 65(22): 10188 - 10191.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. Zieger, L. Dyrskjot, C. Wiuf, J. L. Jensen, C. L. Andersen, K. M.-E. Jensen, and T. F. Orntoft
Role of Activating Fibroblast Growth Factor Receptor 3 Mutations in the Development of Bladder Tumors
Clin. Cancer Res., November 1, 2005; 11(21): 7709 - 7719.
[Abstract] [Full Text] [PDF]


Home page
BioinformaticsHome page
X. Di, H. Matsuzaki, T. A. Webster, E. Hubbell, G. Liu, S. Dong, D. Bartell, J. Huang, R. Chiles, G. Yang, et al.
Dynamic model based algorithms for screening and genotyping over 100K SNPs on oligonucleotide microarrays
Bioinformatics, May 1, 2005; 21(9): 1958 - 1963.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.